Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00130858
Status:
COMPLETED
Last Update Posted:
2009-04-02
First Post:
2005-08-15
Brief Title:
a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4
Sponsor:
Cooperative Weichteilsarkom Study Group
Organization:
Cooperative Weichteilsarkom Study Group
Study Overview
Official Title:
a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4
Status:
COMPLETED
Status Verified Date:
2009-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Phase II Study to evaluate the response on two blocks of topotecan and carboplatin
Detailed Description:
Phase II study for patients with chemosensible soft tissue sarcoma stage IV in children and adolescents response according to RECIST criteria following two blocks of combination therapy consisting of Topotecan and carboplatin
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None